Table 3 Areas under the receiver operating characteristic curve (AUROCs) for NLP models that interpret imaging report text to ascertain clinical outcomes, as evaluated in the labeled test set.

From: Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset

Clinical outcome

Models trained on imaging reports for patients with all listed cancer types

All patients

Breast cancer

Colorectal cancer

NSCLC

Pancreatic cancer

Prostate cancer

Renal cell carcinoma

Urothelial carcinoma

Any cancer

0.98

0.98

0.98

0.97

0.97

0.98

0.97

0.97

Progression

0.95

0.95

0.96

0.96

0.93

0.96

0.96

0.94

Response

0.97

0.98

0.99

0.96

0.97

0.94

0.97

0.99

Brain metastasis

0.99

0.97

1.0

0.99

1.0

0.98

0.97

*

Bone metastasis

0.99

0.98

0.99

0.98

0.99

0.98

0.99

0.99

Adrenal metastasis

0.99

0.99

0.99

1.0

1.0

*

0.95

0.99

Liver metastasis

0.99

1.0

0.99

1.0

0.97

0.98

1.0

1.0

Lung metastasis

0.98

0.99

0.99

0.97

0.98

0.97

0.98

0.99

Nodal metastasis

0.98

0.99

0.97

0.98

0.96

0.99

0.99

0.97

Peritoneal metastasis

0.99

0.99

0.99

1.0

0.96

1.0

*

0.81

Models trained on imaging reports for patients with all cancers except for the type under evaluation

Any cancer

0.98

0.98

0.95

0.95

0.98

0.98

0.96

Progression

0.94

0.96

0.96

0.92

0.96

0.95

0.94

Response

0.98

0.99

0.96

0.97

0.94

0.96

0.99

Brain metastasis

0.97

1.0

0.99

1.0

0.98

0.99

*

Bone metastasis

0.97

0.98

0.98

0.99

0.98

0.99

1.0

Adrenal metastasis

0.99

0.99

0.99

1.0

*

0.94

0.99

Liver metastasis

1.0

0.99

0.99

0.96

0.98

1.0

1.0

Lung metastasis

0.99

0.99

0.94

0.97

0.97

0.97

0.99

Nodal metastasis

0.99

0.98

0.98

0.96

0.99

0.99

0.97

Peritoneal metastasis

0.99

0.98

1.0

0.97

1.0

*

0.77

  1. *Not enough variation in outcome label to evaluate AUROC
  2. †Not applicable